SANOFI Pasteur has announced
that its dengue vaccine has entered
the third and final stage of
development.
Australia will kick off the first of
the stage three studies, as part of
Sanofi’s global dengue vaccine trial
program, which if proven successful
will see the vaccine move to
regulatory agencies for marketing
approval.
At present there is no treatment
for dengue fever, and Sanofi’s
vaccine is the first in the world to
reach final clinical trials.The above article was sent to subscribers in Pharmacy Daily's issue from 05 Nov 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Nov 10
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.